HITACHI/SINGTEL
26.8.2024 03:01:25 CEST | Business Wire | Press release
Singtel and Hitachi, Ltd. (TSE: 6501) have signed a Memorandum of Understanding (MOU) to collaborate on next-generation data centers and GPU Cloud in Japan and potentially the wider Asia Pacific region under the lead of Singtel's Digital InfraCo unit. The strategic partnership will combine Singtel’s extensive data center and connectivity expertise and technology platforms with Hitachi’s differentiating capability that enables end-to-end data center integration including green power solutions, cooling systems, storage infrastructure and data management. Together, the companies intend to sustainably enhance data center performance and capabilities, thereby accelerating AI adoption and digital transformation of enterprises.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240825413497/en/
From left to right: Bill Chang, CEO of Singtel’s Digital InfraCo; Toshiaki Tokunaga, Executive Vice President, Hitachi, Ltd. (Photo: Business Wire)
Notably, the agreement expands on a partnership announced by the companies in June 2024*1 to trial and integrate Singtel’s Paragon, the all-in-one orchestration platform for 5G, edge computing and cloud, with Hitachi’s AI applications for Hitachi’s manufacturing operations as well as enterprise customers. Through Singtel’s Paragon platform and Hitachi’s deep AI expertise, both companies aim to address the complexities faced by customers when deploying AI capabilities.
*1 Press release (June 27, 2024) ”Singtel and Hitachi Digital Partner to Accelerate Industrial AI Solutions”
https://www.hitachi.com/New/cnews/month/2024/06/240628a.html
With the rapidly growing demand for AI and cloud services, Japan has become one of the largest and fastest growing data center markets in the Asia Pacific region. The market is expected to achieve a compound annual growth rate of 9.8% and reach US$5 billion by 2028*2.
*2 Structure Research, Japan (Tokyo & Osaka) DCI Report 2023: Data Centre Colocation, Hyperscale Cloud & Interconnection
Mr. Bill Chang, CEO of Singtel’s Digital InfraCo, said, “Our strategic partnership with Hitachi, a leader in digital systems and services fields, opens up new opportunities in a strategically important and expanding Japanese market. Building a strong ecosystem of partners has always been a priority at Singtel to better serve our customers and broaden our global reach. We look forward to bringing our collective expertise, digital assets and solutions to help more enterprises innovate and transform their businesses and operations through the cloud and AI. As we scale our digital capabilities with our partners like Hitachi, we aim to become a leader in the Asia Pacific region.”
Singtel carved out Digital InfraCo in mid-2023 to serve as a catalyst for innovation and economic growth for Asia Pacific’s digital economies. Digital InfraCo’s portfolio includes Nxera, its regional data center arm, subsea cable, and satellite businesses, and Paragon platform which are all crucial to advancing AI in the region. Digital InfraCo plans to launch GPU-as-a-Service (GPUaaS) later this year to better support enterprise AI adoption.
Mr. Toshiaki Tokunaga, Executive Vice President and Executive Officer at Hitachi, said, “Since its inception, Hitachi’s corporate philosophy has centered on addressing the challenges faced by customers and society. As generative AI continues to drive new innovations, the issues of environmental impact due to rising electricity demand is becoming more prominent. Striking a balance between these two factors is a significant mission for Hitachi’s Social Innovation Business. We are delighted to embark on this mission through our strategic alliance with Singtel. By combining Singtel's expertise in the development and operation of sustainable data centers with the comprehensive capabilities of the Hitachi Group, ranging from green power solutions to facility and data management, we aim to enable companies to utilize data centers in an intelligent and environmentally conscious manner; ultimately achieving continuous innovation while promoting sustainability.”
AI-driven data center expansion is a major opportunity for Hitachi’s Social Innovation business expansion and its group businesses such as Hitachi Digital Services, Hitachi Energy and others as the expansion calls for the successful integration of all areas where Hitachi uniquely excels: information technology, operational technology and products.
The key areas covered by the MOU are:
Explore next-generation data center collaboration in Japan and Asia Pacific to address AI demand: Nxera and Hitachi will explore opportunities to develop data centers across Japan and the rest of the Asia Pacific region. With the continued growth in cloud and AI momentum, it is important to operate smart and environmentally sustainable data centers through high efficiency, high quality data center management. Such an initiative would draw on Nxera’s expertise in data center design, building and operation along with Hitachi’s expertise in the production and delivery of data-center-focused equipment, next-generation energy solutions and advanced IT systems management that ensure stable operations within data center environments.
Nxera is developing a platform of sustainable, hyper-connected AI-ready data centers in the region with a total capacity of more than 200MW in addition to 62MW of existing capacity in Singapore.
Combine Singtel's GPU platform with Hitachi's AI expertise to develop enterprise applications: Hitachi will explore using Singtel’s GPUaaS for its internal AI applications and workloads. This effort would allow Hitachi to verify complementary Singtel-based benefits that can enhance Hitachi’s high-performance machine learning, generative AI, and other digital technologies and solutions. Subsequently, it would provide an opportunity for both companies to define more power-efficient methodologies that could advance any enterprise’s sustainability goals.
Based on the results of Hitachi’s internal GPUaaS verification, the companies may also explore the co-creation of enterprise-grade applications that combines Hitachi's expertise, including its generative AI technologies and platform, with Singtel's GPU cloud and Paragon platform. The aim is to further reduce customer development and deployment times as well as management and deployment overhead for AI applications.
About Singtel
Singtel is a leading Asian communications technology group, operating next-generation connectivity, digital infrastructure and digital businesses including regional data centre arm Nxera and regional IT services arm NCS. The Group has presence in Asia, Australia and Africa and reaches over 780 million mobile customers in 21 countries.
For consumers, Singtel delivers a complete and integrated suite of services, including mobile, broadband and TV. For enterprises, Singtel offers a complementary array of workforce mobility solutions, data hosting, cloud, network infrastructure, analytics and cyber security capabilities.
Singtel is dedicated to continuous innovation, harnessing technology to create new and exciting customer experiences, support enterprises in their digital transformation and shape a more sustainable, digital future.
For more information, visit www.singtel.com.
About Hitachi, Ltd.
Hitachi drives Social Innovation Business, creating a sustainable society through the use of data and technology. We solve customers' and society's challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products. Hitachi operates under the business structure of “Digital Systems & Services” - supporting our customers’ digital transformation; “Green Energy & Mobility” - contributing to a decarbonized society through energy and railway systems, and “Connective Industries” - connecting products through digital technology to provide solutions in various industries. Driven by Digital, Green, and Innovation, we aim for growth through co-creation with our customers. The company’s consolidated revenues for fiscal year 2022 (ended March 31, 2023) totaled 10,881.1 billion yen, with 696 consolidated subsidiaries and approximately 320,000 employees worldwide. For more information on Hitachi, please visit the company's website at https://www.hitachi.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240825413497/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom